Nurexone Biologic Inc

Chart & Performance

D1W1MN

P/E

—

P/S

—

EPS

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

Net income

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.

URL

https://nurexone.com/

IPO date

May 08, 2012

Employees

Domiciled in

Incorporated in

Valuation

No data to show